Additionally, increased detection of LPS [26] and decreased LPS-binding protein (LBP) [21, 27] in blood and plasma from PD patients suggest greater exposure of peripheral tissues and immune cells to LPS, supporting the existence of PD-related gut barrier dysfunction. This evidence concerns the gene LBP and Parkinson disease.